Notification

No new Notification messages

Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
Trade Now, Pay Later with up to 4x Leverage
Never miss a good trading opportunity due to low funds with our MTF feature.
NSE BSE
indraprastha medical corp stock

INDRAPRASTHA MEDICAL CORP Share Price

- - (%)
- NSE: INDRAMEDCO

INDRAPRASTHA MEDICAL CORP Share Price Update

As of the latest trading session, INDRAPRASTHA MEDICAL CORP share price is currently at 470.55, which is up by 18.04 from its previous closing. Today, the stock has fluctuated between 440.00 and 474.70. Over the past year, INDRAPRASTHA MEDICAL CORP has achieved a return of 165.70 %. In the last month alone, the return has been 74.30 %. Read More...

INDRAPRASTHA MEDICAL CORP Performance

Day Range

Low440.00 High474.70
470.55

52 Week Range

Low 149.00 High 474.70
470.55

INDRAPRASTHA MEDICAL CORP Share Price

4751

532150

INDRAMEDCO

img img img img
No Data Available

Open Price

453.50

Prev. Close

452.50

Volume (Shares)

628658.00

Total traded value

2958.15

Upper Circuit

543.00

Lower Circuit

362.00

Note: The current prices & values are delayed, Login to your account for live updates.

INDRAPRASTHA MEDICAL CORP Fundamentals


(Standalone)

Market Cap (Cr) 4313.50
PE Ratio (TTM) 29.99
Book Value / Share 52.11
Beta 0.68
ROE 28.92%
EPS (TTM) 15.08
Dividend Yield 0.99%
Net Profit Qtr (Cr) 44.77

INDRAPRASTHA MEDICAL CORP Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 347.86
Operating Expense 293.39
Net Profit 44.77
Net Profit Margin (%) 12.87
Earnings Per Share (EPS) 4.88
EBITDA 72.24
Effective Tax Rate (%) 24.86
Particulars MAR 2024 (Values in Cr)
Revenue 314.73
Operating Expense 278.06
Net Profit 31.17
Net Profit Margin (%) 9.90
Earnings Per Share (EPS) 3.40
EBITDA 53.33
Effective Tax Rate (%) 25.00
Particulars DEC 2023 (Values in Cr)
Revenue 306.46
Operating Expense 270.06
Net Profit 29.44
Net Profit Margin (%) 9.60
Earnings Per Share (EPS) 3.21
EBITDA 51.57
Effective Tax Rate (%) 27.61
Particulars SEP 2023 (Values in Cr)
Revenue 317.00
Operating Expense 277.52
Net Profit 32.85
Net Profit Margin (%) 10.36
Earnings Per Share (EPS) 3.58
EBITDA 54.53
Effective Tax Rate (%) 24.74
Particulars JUN 2023 (Values in Cr)
Revenue 306.51
Operating Expense 269.84
Net Profit 30.50
Net Profit Margin (%) 9.95
Earnings Per Share (EPS) 3.33
EBITDA 50.82
Effective Tax Rate (%) 24.18
Particulars MAR 2024 (Values in Cr)
Revenue 1244.70
Operating Expense 1095.48
Net Profit 123.96
Net Profit Margin (%) 9.95
Earnings Per Share (EPS) 13.52
EBITDA 210.25
Effective Tax Rate (%) 25.37
Particulars MAR 2023 (Values in Cr)
Revenue 1098.67
Operating Expense 991.52
Net Profit 86.15
Net Profit Margin (%) 7.84
Earnings Per Share (EPS) 9.40
EBITDA 160.73
Effective Tax Rate (%) 26.48
Particulars MAR 2022 (Values in Cr)
Revenue 888.16
Operating Expense 812.20
Net Profit 58.62
Net Profit Margin (%) 6.60
Earnings Per Share (EPS) 6.39
EBITDA 117.41
Effective Tax Rate (%) 25.86
Particulars MAR 2021 (Values in Cr)
Revenue 613.38
Operating Expense 609.77
Net Profit 2.33
Net Profit Margin (%) 0.37
Earnings Per Share (EPS) 0.25
EBITDA 40.95
Effective Tax Rate (%) 45.68
Particulars MAR 2020 (Values in Cr)
Revenue 830.77
Operating Expense 783.27
Net Profit 43.62
Net Profit Margin (%) 5.25
Earnings Per Share (EPS) 4.76
EBITDA 87.08
Effective Tax Rate (%) 9.48
Particulars MAR 2024 (Values in Cr)
Book Value / Share 52.12
ROE % 28.92
ROCE % 35.91
Total Debt to Total Equity 0.04
EBITDA Margin 16.89
Particulars MAR 2023 (Values in Cr)
Book Value / Share 41.39
ROE % 24.44
ROCE % 32.14
Total Debt to Total Equity 0.01
EBITDA Margin 14.63
Particulars MAR 2022 (Values in Cr)
Book Value / Share 35.50
ROE % 19.60
ROCE % 25.61
Total Debt to Total Equity 0.01
EBITDA Margin 13.22
Particulars MAR 2021 (Values in Cr)
Book Value / Share 29.75
ROE % 1.01
ROCE % 2.83
Total Debt to Total Equity 0.01
EBITDA Margin 6.79
Particulars MAR 2020 (Values in Cr)
Book Value / Share 29.21
ROE % 17.04
ROCE % 18.98
Total Debt to Total Equity 0.05
EBITDA Margin 10.48
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 224.43
Total Assets 723.24
Total Liabilities 723.24
Total Equity 477.76
Share Outstanding 91673000
Price to Book Ratio 3.30
Return on Assets (%) 17.13
Return on Capital (%) 25.95
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 128.75
Total Assets 555.14
Total Liabilities 555.14
Total Equity 379.45
Share Outstanding 91673000
Price to Book Ratio 1.88
Return on Assets (%) 15.51
Return on Capital (%) 22.7
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 68.45
Total Assets 461.71
Total Liabilities 461.71
Total Equity 325.44
Share Outstanding 91673000
Price to Book Ratio 1.65
Return on Assets (%) 12.69
Return on Capital (%) 18.01
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 27.52
Total Assets 431.95
Total Liabilities 431.95
Total Equity 272.75
Share Outstanding 91673000
Price to Book Ratio 1.81
Return on Assets (%) 0.53
Return on Capital (%) 0.85
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 24.01
Total Assets 448.99
Total Liabilities 448.99
Total Equity 267.80
Share Outstanding 91673000
Price to Book Ratio 1.16
Return on Assets (%) 9.71
Return on Capital (%) 16.05
Particulars MAR 2024 (Values in Cr)
Net Income 166.11
Cash from Operations 246.99
Cash from Investing -158.43
Cash from Financing -32.38
Net change in Cash 9.34
Free Cash Flow 316.38
Particulars MAR 2023 (Values in Cr)
Net Income 117.18
Cash from Operations 154.41
Cash from Investing -107.91
Cash from Financing -26.04
Net change in Cash 10.52
Free Cash Flow 198.99
Particulars MAR 2022 (Values in Cr)
Net Income 79.07
Cash from Operations 113.82
Cash from Investing -74.11
Cash from Financing -3.37
Net change in Cash 16.82
Free Cash Flow 143.29
Particulars MAR 2021 (Values in Cr)
Net Income 4.29
Cash from Operations 36.18
Cash from Investing -19.08
Cash from Financing -3.14
Net change in Cash 4.59
Free Cash Flow 57.14
Particulars MAR 2020 (Values in Cr)
Net Income 48.19
Cash from Operations 99.10
Cash from Investing -40.19
Cash from Financing -42.74
Net change in Cash 3.51
Free Cash Flow 140.02
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6933.80 96.24 14.39 99697.41 4727.00 / 7043.40
FORTIS MALAR HOSPITALS LIMITED 60.90 0.00 1.04 114.14 44.00 / 107.94
SHREE PACETRONIX LTD. 180.45 22.67 4.98 64.95 138.00 / 391.90
TRANSGENE BIOTEK LTD. 8.40 0.00 5.94 63.65 3.84 / 12.46
VIMTA LABS LIMITED 648.00 34.97 4.49 1436.65 390.60 / 672.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6933.80 95.13 12.92 99697.41 4727.00 / 7043.40
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 37.00 0.00 -84.67 27.64 23.00 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 5485.75 30.87 6.75 6001.41 2377.20 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 434.50
  • 26 Days 367.80
  • 10 Days 418.40
  • 50 Days 327.00
  • 12 Days 410.50
  • 100 Days 292.90
  • 20 Days 388.20
  • 200 Days 215.70
454.03
PIVOT
First Resistance 467.82
Second Resistance 483.13
Third Resistance 496.92
First Support 438.72
Second Support 424.93
Third Support 409.62
RSI 88.38
MACD 42.77
Commodity Channel Index (CCI) 139.43
ADX 70.57
Williams % R -12.11

Over 1 Month

down

74.30

Over 3 Months

down

95.84

Over 6 Months

down

157.39

Over 1 Year

down

165.70

Over 3 Years

down

77.91

Over 5 Years

down

64.29

 

 

 

INDRAPRASTHA MEDICAL CORP Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
44.68
Promoter Holdings
50.99
FII
1.69
DII
2.61
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
President Of Induia Shareholding of Promoter and Promoter Group 2.3834196E7 26.0
Apollo Hospitals Eneterprise Limited Shareholding of Promoter and Promoter Group 2.019074E7 22.02
Quant Mutual Fund - Quant Small Cap Fund Public Shareholding 2396081.0 2.61
Emedlife Insurance Broking Services Limited Public Shareholding 1577649.0 1.72
Vanaja Sundar Iyer Public Shareholding 1523583.0 1.66
Wedgewood Holdings Limited Shareholding of Promoter and Promoter Group 1475000.0 1.61
Citadel Research And Solutions Limited Public Shareholding 1199285.0 1.31
Pcr Investments Limited Shareholding of Promoter and Promoter Group 387423.0 0.42
Prathap C Reddy Shareholding of Promoter and Promoter Group 237187.0 0.26
Preetha Reddy Shareholding of Promoter and Promoter Group 202650.0 0.22
Sucharitha P Reddy Shareholding of Promoter and Promoter Group 160689.0 0.18
Suneeta Reddy Shareholding of Promoter and Promoter Group 138293.0 0.15
Shobana Kamineni Shareholding of Promoter and Promoter Group 116918.0 0.13
Sangita Reddy Shareholding of Promoter and Promoter Group 9900.0 0.01
Vineeta Rai Shareholding of Promoter and Promoter Group 1.0 0.0
Ramesh Chander Shareholding of Promoter and Promoter Group 1.0 0.0
P V Jayakrishnan Shareholding of Promoter and Promoter Group 1.0 0.0
K S Baidwan Shareholding of Promoter and Promoter Group 1.0 0.0

INDRAPRASTHA MEDICAL CORP

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-15 3.0 Final 2023-09-16 Equity shares 2022-09-15 2.5 Final 2022-09-17 Equity shares 2019-09-12 1.6 Final 2019-09-14 Equity shares 2018-09-12 1.5 Final 2018-09-15 Equity shares 2017-09-14 1.8 Final 2017-09-16 Equity shares 2016-08-18 1.8 Final 2016-08-20 Equity shares 2015-09-16 1.8 Final 2015-09-19 Equity shares 2014-09-18 1.8 Final 2014-09-20 Equity shares 2013-09-19 1.6 Final 2013-09-21 Equity shares 2012-09-06 1.6 Final 2012-09-08 Equity shares 2011-09-05 1.6 Final 2011-09-07 Equity shares 2010-08-30 1.6 Final 2010-09-01 Equity shares 2009-08-27 1.5 Final 2009-08-31 Equity shares 2008-08-28 1.4 Final 2008-08-30 Equity shares 2007-09-07 1.25 Final 2007-09-11 Equity shares 2005-08-18 0.0 Final 2005-08-22 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About INDRAPRASTHA MEDICAL CORP

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by INDRAPRASTHA MEDICAL CORP

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Indraprastha Medical Corporation Ltd?

Answer Field

The share price of Indraprastha Medical Corporation Ltd for NSE is ₹ 470.55 and for BSE is ₹ 471.4.

What is the Market Cap of Indraprastha Medical Corporation Ltd?

Answer Field

The market cap of Indraprastha Medical Corporation Ltd for NSE is ₹ 43,13.50 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Indraprastha Medical Corporation Ltd?

Answer Field

The 52 Week High and Low of Indraprastha Medical Corporation Ltd for NSE is ₹ 474.70 and ₹ 149.00 and for BSE is ₹ 474.30 and ₹ 150.00.

How to Buy Indraprastha Medical Corporation Ltd share?

Answer Field

You can trade in Indraprastha Medical Corporation Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Indraprastha Medical Corporation Ltd?

Answer Field

The 1 year returns on the stock has been 165.70%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4800 Cr MTF Book

icon-with-text
loader